Pre-clinical trials from a top preclinical CRO in Kiev, UA.

Our company is an independent CRO based in the United States that provides pre-clinical drug testing in top-notch, GLP certified testing facilities in Eastern Europe. Our research laboratories are supported by the UNAMS and Ministry of Health and provide support for commercial development of new drug discoveries as part of their main purpose. Our business was created to provide the top-notch, lower cost services of these facilities to emerging biotech companies in the United States and Europe, thereby providing them with an attractive option for advancing development programs rapidly and at much lower cost than other commercial CROs. We offer a broad range of pre-clinical CRO including medicine safety, acute and chronic toxicity, pharmacological screening, bioavailability, bioequivalence, and extensive in vitro and in vivo screening for anti-cancer activity.

Our preclinical Contract Research Organization is able to price preclinical trials far below other Contract Research Organizations since we maintain a very low overhead in the USA and conduct all research in Kiev where personnel and lab costs are much lower. Our team in the USA consists only of the organization principals who deal directly with clients; we don’t have any promotion expenses aside from our site, and no main offices, supporting staff or other overhead to increase prices. We have much lower trials conduct prices in Kiev due to much lower workers rates and are able to offer our best rates for long-term and more intricate pre-clinical studies where labor is the most significant part of the overall price. Since we utilize the same reliable international suppliers for animal models, reagents and lab supplies as other Contract Research Organizations, we don’t have any cost savings on these materials and so less overall cost savings for very short-term preclinical studies. However, regardless of your test protocol and length, our goal is to provide our customers the best possible value for their investment.

Tags: , , , , , ,

Related posts